Creative Planning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,000
Closed -$55K 1928
2019
Q4
$55K Hold
1,000
﹤0.01% 1814
2019
Q3
$15K Buy
+1,000
New +$274K ﹤0.01% 1878
2017
Q1
Sell
-500
Closed -$1K 4712
2016
Q4
$1K Buy
+500
New +$67K ﹤0.01% 4418
2015
Q4
Sell
-10,000
Closed -$18K 4442
2015
Q3
$18K Hold
10,000
﹤0.01% 2796
2015
Q2
$137K Buy
+10,000
New +$1.6M ﹤0.01% 946

Other funds holding ELV

Creative Planning's ELV Position: Q1 2026 in Review

Creative Planning reduced its Elevance Health (ELV) stake by 12% in Q1 2026, selling an estimated $1.15M and leaving 26,847 shares worth $7.86M. The position accounts for 0.01% of the portfolio, ranked #858.

Creative Planning first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Creative Planning held 26,847 shares of Elevance Health worth $7.86M as of Q1 2026.
  • Creative Planning sold 3,514 Elevance Health shares in Q1 2026, an estimated $1.15M.
  • Elevance Health made up 0.01% of Creative Planning's portfolio in Q1 2026, its #858 holding.
  • Creative Planning first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Creative Planning's Elevance Health position peaked at $16.9M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.